Working Together to Find a Cure     Print Page | Close Window

Corporate Profile

Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases such as Sanfilippo disorder, Batten disease, Fanconi anemia and other rare disorders.

Stock Chart

Stock chart for: ABEO.O.  Currently trading at $5.55 with a 52 week high of $9.44 and a 52 week low of $2.31.

Stock Quote

ABEO $5.55 - 0.15 (0.00%)
Exchange: NASDAQ CM
Today’s High: $5.75
Today’s Low: $5.45
52 Week High: $9.44
52 Week Low: $2.31
Today’s Volume: 142,573
As of May 26, 2017Refresh quote

Upcoming Events

Wednesday, May 31, 2017 through Thursday, June 1, 2017
Neurotech Investing and Partnering Conference
Tuesday, June 6, 2017 through Friday, June 9, 2017
Jefferies 2017 Global International Healthcare Conference
Tuesday, June 13, 2017 through Wednesday, June 14, 2017
Plasma Protein Forum
Monday, June 19, 2017 through Thursday, June 22, 2017
BIO International Conference 2017
Receive Email AlertsEmail Alert Icon
Sign up to receive email alerts whenever Abeona Therapeutics posts new information to the site. Just enter your email address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.